Driving Access to Care: Use of Mobile Units for Urine Specimen Collection During the Coronavirus Disease-19 (COVID-19) Pandemic
Patients with substance use disorders (SUD) are at increased risk of both coronavirus disease-19 complications as well as exacerbations of their current conditions due to social distancing and isolation. Innovations that provide increased access to support substance use disorder patients may mitigat...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-09-01
|
Series: | Academic Pathology |
Online Access: | https://doi.org/10.1177/2374289520953557 |
id |
doaj-d8c156b924964ed6bc9c59fc90bb5fc3 |
---|---|
record_format |
Article |
spelling |
doaj-d8c156b924964ed6bc9c59fc90bb5fc32020-11-25T03:33:03ZengSAGE PublishingAcademic Pathology2374-28952020-09-01710.1177/2374289520953557Driving Access to Care: Use of Mobile Units for Urine Specimen Collection During the Coronavirus Disease-19 (COVID-19) PandemicJill S. Warrington MD, PhD0Alexa Brett BAS1Heather Foster2Jamie Brandon BA3Samuel Francis-Fath BS4Michael Joseph BS5Mark Fung MD, PhD6 Department of Pathology and Laboratory Medicine, Robert Larner College of Medicine, , VT, USA Aspenti Health, South Burlington, VT, USA Aspenti Health, South Burlington, VT, USA Aspenti Health, South Burlington, VT, USA Aspenti Health, South Burlington, VT, USA True Vector Management Consulting, Milton, VT, USA Department of Pathology and Laboratory Medicine, Robert Larner College of Medicine, , VT, USAPatients with substance use disorders (SUD) are at increased risk of both coronavirus disease-19 complications as well as exacerbations of their current conditions due to social distancing and isolation. Innovations that provide increased access to support substance use disorder patients may mitigate long-term sequelae associated with continued or renewed drug use. To improve patient access during the coronavirus disease-19 pandemic, we deployed a mobile unit to enable access to urine drug testing where needed for patients suffering from substance use disorder. Over a 3-week pilot program, 54 patients received urine drug testing across 5 providers and 8 zip codes. The mobile unit was cost-effective, demonstrating a volume-dependent 19% lower cost compared to pre-coronavirus disease-19 patient service centers in a similar geographic region. The mobile unit was well-received by patients and providers with an average of 9 out of 10 satisfaction scores and allowed for access to urine drug testing for 67% patients who would not have received testing during this time frame. No statistically significant differences were found in substance use positivity rates in comparison to pre-coronavirus disease findings; however, some shifts in use included higher rates of fentanyl and opioid positivity and reductions in tetrahydrocannabinol and cocaine use in the mobile collections setting. Deployment of mobile collection services during the coronavirus disease-19 pandemic has shown to be an effective mechanism for supporting patients suffering from substance use disorder, allowing for access to care of this often stigmatized, vulnerable population.https://doi.org/10.1177/2374289520953557 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jill S. Warrington MD, PhD Alexa Brett BAS Heather Foster Jamie Brandon BA Samuel Francis-Fath BS Michael Joseph BS Mark Fung MD, PhD |
spellingShingle |
Jill S. Warrington MD, PhD Alexa Brett BAS Heather Foster Jamie Brandon BA Samuel Francis-Fath BS Michael Joseph BS Mark Fung MD, PhD Driving Access to Care: Use of Mobile Units for Urine Specimen Collection During the Coronavirus Disease-19 (COVID-19) Pandemic Academic Pathology |
author_facet |
Jill S. Warrington MD, PhD Alexa Brett BAS Heather Foster Jamie Brandon BA Samuel Francis-Fath BS Michael Joseph BS Mark Fung MD, PhD |
author_sort |
Jill S. Warrington MD, PhD |
title |
Driving Access to Care: Use of Mobile Units for Urine Specimen Collection During the Coronavirus Disease-19 (COVID-19) Pandemic |
title_short |
Driving Access to Care: Use of Mobile Units for Urine Specimen Collection During the Coronavirus Disease-19 (COVID-19) Pandemic |
title_full |
Driving Access to Care: Use of Mobile Units for Urine Specimen Collection During the Coronavirus Disease-19 (COVID-19) Pandemic |
title_fullStr |
Driving Access to Care: Use of Mobile Units for Urine Specimen Collection During the Coronavirus Disease-19 (COVID-19) Pandemic |
title_full_unstemmed |
Driving Access to Care: Use of Mobile Units for Urine Specimen Collection During the Coronavirus Disease-19 (COVID-19) Pandemic |
title_sort |
driving access to care: use of mobile units for urine specimen collection during the coronavirus disease-19 (covid-19) pandemic |
publisher |
SAGE Publishing |
series |
Academic Pathology |
issn |
2374-2895 |
publishDate |
2020-09-01 |
description |
Patients with substance use disorders (SUD) are at increased risk of both coronavirus disease-19 complications as well as exacerbations of their current conditions due to social distancing and isolation. Innovations that provide increased access to support substance use disorder patients may mitigate long-term sequelae associated with continued or renewed drug use. To improve patient access during the coronavirus disease-19 pandemic, we deployed a mobile unit to enable access to urine drug testing where needed for patients suffering from substance use disorder. Over a 3-week pilot program, 54 patients received urine drug testing across 5 providers and 8 zip codes. The mobile unit was cost-effective, demonstrating a volume-dependent 19% lower cost compared to pre-coronavirus disease-19 patient service centers in a similar geographic region. The mobile unit was well-received by patients and providers with an average of 9 out of 10 satisfaction scores and allowed for access to urine drug testing for 67% patients who would not have received testing during this time frame. No statistically significant differences were found in substance use positivity rates in comparison to pre-coronavirus disease findings; however, some shifts in use included higher rates of fentanyl and opioid positivity and reductions in tetrahydrocannabinol and cocaine use in the mobile collections setting. Deployment of mobile collection services during the coronavirus disease-19 pandemic has shown to be an effective mechanism for supporting patients suffering from substance use disorder, allowing for access to care of this often stigmatized, vulnerable population. |
url |
https://doi.org/10.1177/2374289520953557 |
work_keys_str_mv |
AT jillswarringtonmdphd drivingaccesstocareuseofmobileunitsforurinespecimencollectionduringthecoronavirusdisease19covid19pandemic AT alexabrettbas drivingaccesstocareuseofmobileunitsforurinespecimencollectionduringthecoronavirusdisease19covid19pandemic AT heatherfoster drivingaccesstocareuseofmobileunitsforurinespecimencollectionduringthecoronavirusdisease19covid19pandemic AT jamiebrandonba drivingaccesstocareuseofmobileunitsforurinespecimencollectionduringthecoronavirusdisease19covid19pandemic AT samuelfrancisfathbs drivingaccesstocareuseofmobileunitsforurinespecimencollectionduringthecoronavirusdisease19covid19pandemic AT michaeljosephbs drivingaccesstocareuseofmobileunitsforurinespecimencollectionduringthecoronavirusdisease19covid19pandemic AT markfungmdphd drivingaccesstocareuseofmobileunitsforurinespecimencollectionduringthecoronavirusdisease19covid19pandemic |
_version_ |
1724565070298480640 |